Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease

Richard K. Burt, Malcolm Brenner, William Burns, Eva Courier, Gary Firestein, Bevra Hahn, Helen Heslop, Charles Link, Henry McFarland, Martin Roland, Mary Territo, George Tsokos, Ann Traynor

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

In phase I (safety) trials, we have demonstrated the feasibility of autologous hematopoietic stem cell transplantation (HSCT) for patients with autoimmune diseases. Although this review comments on results of our phase I trials, the focus is on phase II (efficacy) trials using gene-marked autologous stem cells.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalJournal of Clinical Immunology
Volume20
Issue number1
DOIs
StatePublished - 2000

Keywords

  • Autoimmune disease
  • Gene-marked autologous stem cells
  • Hematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease'. Together they form a unique fingerprint.

Cite this